Home > Research > Publications & Outputs > Genetic variants at chromosome 9p21 and risk of...
View graph of relations

Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. / Patel, Riyaz S.; Asselbergs, Folkert W.; Quyyumi, Arshed A. et al.
In: Journal of the American College of Cardiology, Vol. 63, No. 21, 03.06.2014, p. 2234-2245.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Patel, RS, Asselbergs, FW, Quyyumi, AA, Palmer, TM, Finan, CI, Tragante, V, Deanfield, J, Hemingway, H, Hingorani, AD & Holmes, MV 2014, 'Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis', Journal of the American College of Cardiology, vol. 63, no. 21, pp. 2234-2245. https://doi.org/10.1016/j.jacc.2014.01.065

APA

Patel, R. S., Asselbergs, F. W., Quyyumi, A. A., Palmer, T. M., Finan, C. I., Tragante, V., Deanfield, J., Hemingway, H., Hingorani, A. D., & Holmes, M. V. (2014). Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. Journal of the American College of Cardiology, 63(21), 2234-2245. https://doi.org/10.1016/j.jacc.2014.01.065

Vancouver

Patel RS, Asselbergs FW, Quyyumi AA, Palmer TM, Finan CI, Tragante V et al. Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2014 Jun 3;63(21):2234-2245. doi: 10.1016/j.jacc.2014.01.065

Author

Patel, Riyaz S. ; Asselbergs, Folkert W. ; Quyyumi, Arshed A. et al. / Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events : a systematic review and meta-analysis. In: Journal of the American College of Cardiology. 2014 ; Vol. 63, No. 21. pp. 2234-2245.

Bibtex

@article{4a94513f3a9d45c9862285f4e9d839ea,
title = "Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis",
abstract = "OBJECTIVES: The purpose of this analysis was to compare the association between variants at the chromosome 9p21 locus (Ch9p21) and risk of first versus subsequent coronary heart disease (CHD) events through systematic review and meta-analysis.BACKGROUND: Ch9p21 is a recognized risk factor for a first CHD event. However, its association with risk of subsequent events in patients with established CHD is less clear.METHODS: We searched PubMed and EMBASE for prospective studies reporting association of Ch9p21 with incident CHD events and extracted information on cohort type (individuals without prior CHD or individuals with established CHD) and effect estimates for risk of events.RESULTS: We identified 31 cohorts reporting on 193,372 individuals. Among the 16 cohorts of individuals without prior CHD (n = 168,209), there were 15,664 first CHD events. Ch9p21 was associated with a pooled hazard ratio (HR) of a first event of 1.19 (95% confidence interval: 1.17 to 1.22) per risk allele. In individuals with established CHD (n = 25,163), there were 4,436 subsequent events providing >99% and 91% power to detect a per-allele HR of 1.19 or 1.10, respectively. The pooled HR for subsequent events was 1.01 (95% confidence interval: 0.97 to 1.06) per risk allele. There was strong evidence of heterogeneity between the effect estimates for first and subsequent events (p value for heterogeneity = 5.6 × 10(-11)). We found no evidence for biases to account for these findings.CONCLUSIONS: Ch9p21 shows differential association with risk of first versus subsequent CHD events. This has implications for genetic risk prediction in patients with established CHD and for mechanistic understanding of how Ch9p21 influences risk of CHD.",
keywords = "Animals, Chromosomes, Human, Pair 9, Coronary Disease, Genetic Predisposition to Disease, Genetic Variation, Humans, Polymorphism, Single Nucleotide, Risk Factors",
author = "Patel, {Riyaz S.} and Asselbergs, {Folkert W.} and Quyyumi, {Arshed A.} and Palmer, {Tom M.} and Finan, {Chris I.} and Vinicius Tragante and John Deanfield and Harry Hemingway and Hingorani, {Aroon D.} and Holmes, {Michael V.}",
note = " Copyright {\textcopyright} 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2014",
month = jun,
day = "3",
doi = "10.1016/j.jacc.2014.01.065",
language = "English",
volume = "63",
pages = "2234--2245",
journal = "Journal of the American College of Cardiology",
issn = "1558-3597",
publisher = "Elsevier USA",
number = "21",

}

RIS

TY - JOUR

T1 - Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events

T2 - a systematic review and meta-analysis

AU - Patel, Riyaz S.

AU - Asselbergs, Folkert W.

AU - Quyyumi, Arshed A.

AU - Palmer, Tom M.

AU - Finan, Chris I.

AU - Tragante, Vinicius

AU - Deanfield, John

AU - Hemingway, Harry

AU - Hingorani, Aroon D.

AU - Holmes, Michael V.

N1 - Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

PY - 2014/6/3

Y1 - 2014/6/3

N2 - OBJECTIVES: The purpose of this analysis was to compare the association between variants at the chromosome 9p21 locus (Ch9p21) and risk of first versus subsequent coronary heart disease (CHD) events through systematic review and meta-analysis.BACKGROUND: Ch9p21 is a recognized risk factor for a first CHD event. However, its association with risk of subsequent events in patients with established CHD is less clear.METHODS: We searched PubMed and EMBASE for prospective studies reporting association of Ch9p21 with incident CHD events and extracted information on cohort type (individuals without prior CHD or individuals with established CHD) and effect estimates for risk of events.RESULTS: We identified 31 cohorts reporting on 193,372 individuals. Among the 16 cohorts of individuals without prior CHD (n = 168,209), there were 15,664 first CHD events. Ch9p21 was associated with a pooled hazard ratio (HR) of a first event of 1.19 (95% confidence interval: 1.17 to 1.22) per risk allele. In individuals with established CHD (n = 25,163), there were 4,436 subsequent events providing >99% and 91% power to detect a per-allele HR of 1.19 or 1.10, respectively. The pooled HR for subsequent events was 1.01 (95% confidence interval: 0.97 to 1.06) per risk allele. There was strong evidence of heterogeneity between the effect estimates for first and subsequent events (p value for heterogeneity = 5.6 × 10(-11)). We found no evidence for biases to account for these findings.CONCLUSIONS: Ch9p21 shows differential association with risk of first versus subsequent CHD events. This has implications for genetic risk prediction in patients with established CHD and for mechanistic understanding of how Ch9p21 influences risk of CHD.

AB - OBJECTIVES: The purpose of this analysis was to compare the association between variants at the chromosome 9p21 locus (Ch9p21) and risk of first versus subsequent coronary heart disease (CHD) events through systematic review and meta-analysis.BACKGROUND: Ch9p21 is a recognized risk factor for a first CHD event. However, its association with risk of subsequent events in patients with established CHD is less clear.METHODS: We searched PubMed and EMBASE for prospective studies reporting association of Ch9p21 with incident CHD events and extracted information on cohort type (individuals without prior CHD or individuals with established CHD) and effect estimates for risk of events.RESULTS: We identified 31 cohorts reporting on 193,372 individuals. Among the 16 cohorts of individuals without prior CHD (n = 168,209), there were 15,664 first CHD events. Ch9p21 was associated with a pooled hazard ratio (HR) of a first event of 1.19 (95% confidence interval: 1.17 to 1.22) per risk allele. In individuals with established CHD (n = 25,163), there were 4,436 subsequent events providing >99% and 91% power to detect a per-allele HR of 1.19 or 1.10, respectively. The pooled HR for subsequent events was 1.01 (95% confidence interval: 0.97 to 1.06) per risk allele. There was strong evidence of heterogeneity between the effect estimates for first and subsequent events (p value for heterogeneity = 5.6 × 10(-11)). We found no evidence for biases to account for these findings.CONCLUSIONS: Ch9p21 shows differential association with risk of first versus subsequent CHD events. This has implications for genetic risk prediction in patients with established CHD and for mechanistic understanding of how Ch9p21 influences risk of CHD.

KW - Animals

KW - Chromosomes, Human, Pair 9

KW - Coronary Disease

KW - Genetic Predisposition to Disease

KW - Genetic Variation

KW - Humans

KW - Polymorphism, Single Nucleotide

KW - Risk Factors

U2 - 10.1016/j.jacc.2014.01.065

DO - 10.1016/j.jacc.2014.01.065

M3 - Journal article

C2 - 24607648

VL - 63

SP - 2234

EP - 2245

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 1558-3597

IS - 21

ER -